| 000 | 01759 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515080250.0 | ||
| 264 | 0 | _c20070830 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161207781368729 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBois, Patrick | |
| 245 | 0 | 0 |
_aMolecular regulation and pharmacology of pacemaker channels. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2007 |
||
| 300 |
_a2338-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiological Clocks _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xcytology |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 | _aCyclic Nucleotide-Gated Cation Channels |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHyperpolarization-Activated Cyclic Nucleotide-Gated Channels |
| 650 | 0 | 4 |
_aIon Channel Gating _xdrug effects |
| 650 | 0 | 4 |
_aIon Channels _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Channels _xchemistry |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aSinoatrial Node _xcytology |
| 700 | 1 | _aGuinamard, Romain | |
| 700 | 1 | _aChemaly, Antoun E L | |
| 700 | 1 | _aFaivre, Jean-François | |
| 700 | 1 | _aBescond, Jocelyn | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 13 _gno. 23 _gp. 2338-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161207781368729 _zAvailable from publisher's website |
| 999 |
_c17223753 _d17223753 |
||